Case Information
*1 12-2943-cv
SEC v. Bankosky
U NITED S TATES C OURT OF A PPEALS FOR THE S ECOND C IRCUIT August Term 2012 (Argued: April 9, 2013 Decided: May 14, 2013) Docket No. 12-2943-cv S ECURITIES AND E XCHANGE C OMMISSION , Plaintiff-Appellee, v.
B RENT C. B ANKOSKY ,
Defendant-Appellant,
Before:
W ALKER AND C HIN , Circuit Judges , AND R ESTANI , Judge . [*] Appeal from a post-judgment order of the United States District Court for the Southern District of New York (Baer, J. ), barring defendant-appellant from acting as an *2 officer or director of a public company for ten years, pursuant to section 21(d)(2) of the Securities Exchange Act of 1934, 15 U.S.C. § 78u(d)(2).
A FFIRMED .
A LLAN A. C APUTE , Special Counsel to the Solicitor, for Michael A. Conley, Deputy General Counsel and Jacob H. Stillman, Solicitor, Securities and Exchange Commission, Washington, D.C., for Plaintiff-Appellee. R OBERT G. H EIM , Meyers & Heim LLP, New York, New York, for Defendant- Appellant.
P ER C URIAM :
In this case, the Securities and Exchange Commission
(the "SEC") accused defendant-appellant Brent C. Bankosky of
engaging in insider trading, in violation of sections 10(b)
and 14(e) of the Securities Exchange Act of 1934 (the
"Exchange Act"), 15 U.S.C. §§ 78j(b), 78n(e), and SEC Rules
10b-5 and 14e-3. After the entry of a consent judgment, in
which Bankosky neither admitted nor denied the allegations
in the complaint, the SEC moved for an officer and director
*3
bar pursuant to section 21(d)(2) of the Exchange Act, 15
U.S.C. § 78u(d)(2). Relying on the factors in
SEC v.
Patel
,
BACKGROUND
The parties stipulated in the consent judgment that the following factual allegations in the complaint are to be deemed as true solely for the purpose of deciding the SEC's motion for an officer and director bar:
From January 2008 until his resignation in May 2011, Bankosky worked for the pharmaceutical company Takeda Pharmaceuticals International, Inc. ("Takeda"), first as a director of Global Licensing and Business Development and then as a senior director. In these positions, Bankosky had access to, and did obtain, material non-public information regarding Takeda's discussions with outside companies about strategic alliances, mergers, and product *4 acquisitions. Despite a company policy prohibiting trading on such inside information, from 2008 to 2011 Bankosky bought call options in the shares of four companies in advance of anticipated deal announcements between these companies and Takeda. After deals with two of the companies were publicly announced, Bankosky sold the options in those companies and realized profits of $63,000. His option investments in the other two companies netted no gain.
On February 9, 2012, the SEC filed this action below. The consent judgment was entered March 15, 2012, imposing a permanent injunction against further violations, ordering disgorgement of $63,000 plus pre -judgment interest, and imposing a civil penalty of $63,000.
On March 30, 2012, the SEC moved for the district court to bar Bankosky permanently from serving as an officer or director of any company whose shares are registered under the Exchange Act. In support of its motion, the SEC attached excerpts of Bankosky's sworn testimony before the SEC and emails that Bankosky sent while working at Takeda. In the testimony, Bankosky denied *5 having any knowledge about Takeda's entry into a strategic global alliance with Cell Genesys before the public announcement. But emails referenced in the complaint and attached as exhibits to the SEC's motion demonstrate that Bankosky was aware of the confidential negotiations with Cell Genesys and even worked on the project before it went public.
In a May 21, 2012 opinion and order, the district
court evaluated Bankosky's fitness to serve as an officer
or director, applying the six factors set out in
SEC v.
,
This appeal followed.
DISCUSSION
A. Applicable Law
The district court has "substantial discretion in
deciding whether to impose a bar to employment in a public
company." ,
Section 21(d)(2) of the Exchange Act provides that:
the court may prohibit, conditionally or unconditionally, and permanently or for such period of time as it shall determine, any person who violated section [10(b)] of this title or the rules or regulations thereunder from acting as an officer or director of any issuer that has a class of securities registered pursuant to section [12] of this title or that is required to file reports pursuant to section [15(d)] of this title if the person's conduct demonstrates unfitness to serve as an officer or director of any such issuer.
15 U.S.C. § 78u(d)(2). In SEC v. Patel , we identified six non-exclusive factors that were "useful in making the unfitness assessment":
(1) the egregiousness of the underlying securities law violation; (2) the defendant's repeat offender status; (3) the defendant's role or *8 position when he engaged in the fraud; (4) the defendant's degree of scienter; (5) the defendant's economic stake in the violation; and (6) the likelihood that misconduct will recur.
Patel
,
21(d)(2), which permitted a ban only "'if the person's
conduct demonstrates
substantial unfitness
to serve as an
officer or director.'"
Id.
at 140-41 (emphasis added)
(quoting 15 U.S.C. § 78u(d)(2) (1990)). In 2002, Congress
replaced "substantial unfitness" with simply "unfitness."
See
Sarbanes-Oxley Act of 2002 § 305(a), Pub. L. No. 107 -
204, 116 Stat. 745, 778-79 (2002) (amending 15 U.S.C.
§ 78u(d)(2)). Although textually this change is ambiguous,
the legislative history demonstrates that Congress's intent
was to lower the threshold of misconduct for which courts
*9
may impose director and officer bans.
See
S. Rep. No. 107-
205, at 27 (2002),
available at
B. Application
We hold that the district court did not err in
relying on the six factors in this case. The 2002
Amendment, by lowering the threshold of misconduct required
to impose the officer and director bar, did not undermine
*10
the usefulness of the
Patel
factors, which indicate where
evidence of unfitness might be found in a defendant's
misconduct. Whatever the contours of the new standard,
"unfitness" is clearly a lower hurdle than "substantial
unfitness."
See
S. Rep. No. 107-205, at 27 (2002). It
necessarily follows that a person who is "substantially
unfit" under the
Patel
analysis is also "unfit" under the
revised statute. Thus, the
Patel
factors are just as
relevant to determining "unfitness" as they were to
determining "substantial unfitness."
See SEC v.
iShopNoMarkup.com, Inc.
, No. 04-cv-4057,
The six factors were derived from a law review article by Professor Jayne W. Barnard, who, subsequent to the 2002 Amendment, proposed a new set of nine, non-exhaustive factors to guide the determination of "unfitness":
(1) the nature and complexity of the scheme; (2) the defendant's role in the scheme; (3) the use of corporate resources in executing the scheme; (4) the defendant's financial gain (or loss avoidance) from the scheme; (5) the loss to investors and others as a result of the scheme; (6) whether the scheme represents an isolated occurrence or a pattern of misconduct; (7) the defendant's use of stealth and concealment; (8) the defendant's history of business and related misconduct; and (9) the defendant's acknowledgement of wrongdoing and the credibility of his contrition.
Barnard,
Rule 10b-5 and the "Unfitness" Question
, 47 Ariz. L.
Rev. at 46;
see also Patel
,
The SEC, in its brief, opposed the adoption of
Professor Barnard's nine-factor test and, at oral argument,
indicated its preference for the set of factors cited in
Steadman v. SEC
,
[1] the egregiousness of the defendant's actions, [2] the isolated or recurrent nature of the infraction, [3] the degree of scienter involved, [4] the sincerity of the defendant's assurances against future violations, [5] the defendant's recognition of the wrongful nature of his conduct, and [6] the likelihood that the defendant's occupation will present opportunities for future violations.
Steadman
,
Ultimately, we find no "clear error of judgment in
the conclusion that [the district court] reached upon a
weighing of the relevant factors."
In re Am. Express Fin.
Advisors Sec. Litig.
,
CONCLUSION
For the foregoing reasons, the order of the
district court is AFFIRMED.
Notes
[*] The Honorable Jane A. Restani, of the United States Court of International Trade, sitting by designation.
